Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Calibrated clinical judgment in psychiatric drug trials: Beyond psychometric scales.

Created on 24 Jun 2026

Authors

Luca Pani, Gary S Sachs, Nina R Schooler

Published in

Journal of psychiatric research. Volume 201. Pages 240-243. Jun 15, 2026. Epub Jun 15, 2026.

Abstract

Psychiatric randomised controlled trials increasingly privilege psychometric rating scales, yet bedside clinical training, remains the clinician's primary integrator of meaning, context, and change. Recent reconceptualisations describe clinical judgment as a three-stage process encompassing data collection through clinical interviewing, interpretationviaclinical reasoning, and decision making (Fava and Guidi, 2026; Fava et al., 2026). We provide a historically informed, conceptually focused analysis of the transition from narrative clinical impression to operationalised criteria and multi-item scales, and examine the emergence of clinician-judgment outcomes, particularly the Clinical Global Impressions (CGI) scales, as a hybrid bridge between these traditions. We argue that modern outcome assessment comprises two dominant families: multi-item symptom scales (e.g., PANSS, MADRS, HAM-A) and global clinician-judgment scales (CGI-Severity, CGI-Improvement). Global ratings can capture clinically salient information not fully represented by item totals, but only if their use preserves independent judgment. We propose "CGI 2.0": minimum standards for rater qualification, construct-focused training, structured justification, calibration/monitoring, and prespecified concordance/discordance analyses with primary symptom-scale endpoints, while cautioning against "industrialised" practices such as deriving CGI scores from multi-item totals. A clinimetric integration of psychometric methods that re-legitimises calibrated clinical judgment alongside rigorous measurement could improve interpretability, clinical relevance, and signal detection in psychopharmacology trials.

PMID:
42335497
Bibliographic data and abstract were imported from PubMed on 24 Jun 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 9
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement